Brief: ISR Enters Into MoU With UniMed UniHealth In Bangladesh

ISR Immune System Regulation Holding AB (publ)

09/08/2021 13:15

Aug 9 (Reuters) - ISR Immune System Regulation Holding AB
(publ)  ISR.ST :
    * SAID ON SUNDAY ENTERED INTO A MEMORANDUM OF UNDERSTANDING
(MOU)
WITH A PHARMACEUTICAL COMPANY IN BANGLADESH, UNIMED UNIHEALTH
PHARMACEUTICALS LTD
    * THE PURPOSE OF MOU IS TO AGREE ON A LONG-TERM COOPERATION
AGREEMENT WITH A LICENSING AGREEMENT THAT GIVES UNIMED AN
EXCLUSIVE RIGHT TO MANUFACTURE AND DISTRIBUTE ISR'S VACCINE
AGAINST THE SARS-COV-2 VIRUS IN BANGLADESH
    * ISR RECEIVES COMPENSATION IN THE FORM OF A PAYMENT UPON
SIGNING
A LICENSE AGREEMENT AND A PAYMENT WHEN ISR RECEIVES APPROVAL TO
MARKET AND SELL THE VACCINE, AS WELL AS A DOUBLE-DIGIT ROYALTY

    
    
 Source text for Eikon:  urn:newsml:reuters.com:*:nWkrc2JdMZ
    
 Further company coverage:  ISR.ST  
   


 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))